|
Volumn 51, Issue 4, 2008, Pages 694-695
|
Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver
|
Author keywords
Gene therapy; Hepatocytes; Insulin production; Lentiviral vector; Rat; Type 1 diabetes
|
Indexed keywords
GLUCAGON;
HISTIDINE;
HOMEODOMAIN PROTEIN;
INSULIN DERIVATIVE;
INSULIN[B10 ASPARTIC ACID];
LENTIVIRUS VECTOR;
NEUROGENIC DIFFERENTIATION FACTOR;
SOMATOSTATIN;
STREPTOZOCIN;
TRANSCRIPTION FACTOR;
TRANSCRIPTION FACTOR PDX 1;
UNCLASSIFIED DRUG;
CELL DIFFERENTIATION;
DISEASE MODEL;
DRUG EFFECT;
DRUG EFFICACY;
GENETIC TRANSDUCTION;
GLUCOSE BLOOD LEVEL;
GLUCOSE HOMEOSTASIS;
IMMUNOHISTOCHEMISTRY;
INSULIN DEPENDENT DIABETES MELLITUS;
INSULIN RESPONSE;
INSULIN SYNTHESIS;
LETTER;
LIVER CELL;
NONHUMAN;
PANCREAS ISLET BETA CELL;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
STREPTOZOCIN DIABETES;
VIRAL GENE THERAPY;
ANIMALS;
DIABETES MELLITUS, EXPERIMENTAL;
GENE THERAPY;
GLUCOSE TOLERANCE TEST;
HEPATOCYTES;
LENTIVIRUS;
RATS;
RATS, WISTAR;
|
EID: 41149143064
PISSN: 0012186X
EISSN: None
Source Type: Journal
DOI: 10.1007/s00125-008-0931-1 Document Type: Letter |
Times cited : (8)
|
References (7)
|